The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives - Top-Institutions - MDSpire

The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives

  • By

  • Zhongjun Wang

  • QingYuan Bian

  • Yue Chu

  • Wanyue Zhu

  • Ying Qin

  • Jiwei Zheng

  • May 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Microbiome Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Microbiome Research

  • #3

    TUM Klinikum, Technical University of Munich
    TUM Klinikum, Technical University of Munich

    Munich, Bavaria

    Key Differentiators

    • Oncology
    • Head and Neck Surgery

Original Source(s)

The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives

  • by Zhongjun Wang, QingYuan Bian, Yue Chu, Wanyue Zhu, Ying Qin, Jiwei Zheng

  • May 26, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms